These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6741271)

  • 1. [Significance of blocking antibodies in the mechanism of specific desensitization therapy in patients with diffuse neurodermatitis].
    Kalamkarian AA; Samsonov VA; Nurmukhambetov ZhN
    Vestn Dermatol Venerol; 1984 May; (5):8-12. PubMed ID: 6741271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific hyposensitizing therapy of dermatoses with soluble bacterial allergens].
    Nureev GG
    Vestn Dermatol Venerol; 1982 Jul; (7):52-6. PubMed ID: 7136256
    [No Abstract]   [Full Text] [Related]  

  • 5. [Specific immunotherapy].
    Kapp A; Merk HF
    Hautarzt; 2011 Sep; 62(9):648-9. PubMed ID: 21882100
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaching atopic dermatitis treatment differently: from skin barrier preservation to allergen-specific immunotherapy.
    Milani M
    Immunotherapy; 2012 Jun; 4(6):561-4. PubMed ID: 22788121
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of specific immunotherapy (SIT) in atopic dermatitis.
    Werfel T
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():47-9. PubMed ID: 19221619
    [No Abstract]   [Full Text] [Related]  

  • 8. [MMW Drug Prize 2008 awarded. SQ allergens allow allergic patients to breathe deeply].
    Wepner U
    MMW Fortschr Med; 2008 Jun; 150(26-27):21. PubMed ID: 18681225
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of tranilast administration and specific hyposensitization therapy of atopic dermatitis].
    Gondo A; Saeki N; Yamamoto E; Hirabayashi T; Tokuda Y
    Arerugi; 1985 May; 34(5):310-9. PubMed ID: 2412532
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute manifestations due to allergen contact. Apples and nuts can be poisons in neurodermatitis].
    Neumaier J
    MMW Fortschr Med; 2004 Oct; 146(42):16. PubMed ID: 15536699
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
    Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
    Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immunotherapy design questions.
    Moed H; de Bot C; van der Wouden JC
    Allergy; 2006 Jul; 61(7):896. PubMed ID: 16792592
    [No Abstract]   [Full Text] [Related]  

  • 13. [Terminology, clinical picture and treatment of atopic dermatitis and neurodermatitis].
    Romanenko GF; Vyborov AM
    Vestn Dermatol Venerol; 1989; (4):22-6. PubMed ID: 2763704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Theory and practice of specific desensitization therapy of allergic skin diseases].
    Korossy S; Vincze E; Csizér Z; Juhász V
    Orv Hetil; 1972 Oct; 113(43):2579-84. PubMed ID: 5078183
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of IgE reactivities of purified allergens from Candida albicans and Malassezia furfur among patients with atopic dermatitis].
    Asako Y; Saito A; Yasueda H; Kawaguchi H; Akiyama K; Endo M; Onishi Y; Takesako K
    Arerugi; 2002 Aug; 51(8):615-21. PubMed ID: 12368565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis.
    Galli E; Chini L; Nardi S; Benincori N; Panei P; Fraioli G; Moschese V; Rossi P
    Allergol Immunopathol (Madr); 1994; 22(1):18-22. PubMed ID: 8030579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of allergen specific IgE antibodies with atopic dermatitis--evaluation of house dust 6 (house dust Japan) specific IgE antibody].
    Takamura T; Nagata M; Nakagawa H; Hashimoto T
    Rinsho Byori; 1996 Feb; 44(2):163-8. PubMed ID: 8851201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sweat of patients with atopic dermatitis contains specific IgE antibodies to inhalant allergens.
    Jung K; Schlenvoigt G; Ladwig K; Herrmann D; Moths C; Linse R; Neumann C
    Clin Exp Dermatol; 1996 Sep; 21(5):347-50. PubMed ID: 9136153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.